WebJun 7, 2024 · In terms of fundamentals, Last quarter Bio-Techne reported $1.79 EPS on $243.6 million revenue. Earnings grew 29% last quarter, following 36% and 50% growth the prior two periods. Revenue grew 25% ... WebFeb 1, 2024 · Second quarter year-over-year organic growth for the segment was 7 percent, with acquisitions contributing 16 percent to revenue growth. Bio-Techne posted Q2 Protein Sciences revenues of $205.0 million, up 19 percent from $172.2 million in the prior-year quarter. Second quarter year-over-year organic growth for the segment was 19 percent.
Prostate cancer test leads Bio-Techne
WebBio-Techne's Mission is to build Epic Tools for Epic Science. We have a creative, caring team of colleagues throughout the world who bring unique perspectives and talents in support of that Mission and who embody our … The company was founded in 1976 by Dr. Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company. In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company. In July 2013, the company acquired Bionostics for $104 million. In February 2014, the company changed its name to Bio-Techne. howarth road bournemouth
Bio-Techne (TECH) - Revenue
Web18 hours ago · The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash ... WebApr 14, 2024 · The company had revenue of $271.58 million for the quarter, compared to analysts’ expectations of $289.98 million. Bio-Techne had a return on equity of 15.87% … WebApr 11, 2024 · The firm had revenue of $271.58 million during the quarter, compared to the consensus estimate of $289.98 million. Bio-Techne had a return on equity of 15.87% and a net margin of 23.38%. howarth road